web analytics
5.7 C
Munich
Sunday, October 17, 2021

Blue Skies, ClearMask; PKG, Powerful Ascent of Cerebain Biotech Corp OTCMKTS: CBBT)

Cerebain Biotech Corp OTCMKTS: CBBT) is making a spectacular run up the charts in recent months as the company completes the acquisition of PKG, Inc., a developer, and manufacturing company for system-level devices that has worked with numerous Fortune 500 companies over the years. Last Month PKG reported it is set to become the key manufacturer for ClearMask; the first fully transparent, FDA-cleared mask produced in the United States. To meet the rigorous controls necessary for FDA-cleared products, ClearMask LLC and Xometry, the largest marketplace for On-Demand manufacturing, partnered with PKG Inc., an ISO 13485-certified facility, to manufacture the FDA-cleared version of the ClearMask™.  The mask is optimized for maximum clarity and comfort and meets applicable ASTM Level 3 requirements for fluid resistance and flammability, which offers a high level of protection for medical use in environments such as operating rooms.

Microcapdaily first reported on CBBT on October 7 when the stock was around $0.002. we stated at the time: “CBBT has been running up the charts in recent weeks quickly attracting legions of shareholders and emerging as a volume leader in small caps as the Company is in the process of acquiring PKG, Inc., a developer, and manufacturing company for system-level devices with expertise in human-machine interfaces focusing on healthcare, industrial, aerospace and government products. For the past 30 years PKG has been a major contributor in designing and manufacturing numerous and diverse devices for Fortune 500 companies, mid-size organizations, and start-up businesses. With complete in-house vertical integration, PKG provides its customers with all of their product development needs from R&D, design & development, verification & validation, final product manufacturing, product testing, service and warranty and end of life product support and transitioning.

Cerebain Biotech Corp. (OTC: CBBT) is a development-stage medical device company focused on the creation and clinical development of its patent pending minimally invasive implantable device and a synthetic drug solution. The device leverages the clinically observable, positive impact that Omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimer’s disease. The corporate vision is based on these positive clinical observations.

The Company is led by CEO Eric Clemons, a high level executive with a long history building and growing companies across multiple industries. Prior to assuming leadership of Cerebain, he served as President and Chief Operating Officer for GTC Telecom Corp, a publicly traded Nevada Corporation that operated out of Costa Mesa, CA. During his tenure, Mr. Clemons was instrumental in growing the company’s annual revenues from $500,000 per year to over $17 million per year. It was Cerebain technology, which offers a completely new way of approaching the development of an effective Alzheimer’s disease treatment that captured Mr. Clemons’ imagination, triggering his move into the life sciences arena.

“While there have been some very recent key learnings in the Alzheimer’s treatment space, the fact is that the disease remains the only top ten killer in the United States with no effective treatments currently available and no way to halt or slow progression,” Clemons said. “We are hopeful that our device, which will focus on the impact of omental stimulation and cognitive function in Alzheimer’s Disease patients, can change that.”

To Find out the inside Scoop on CBBT Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CBBTPKG, Inc. was established in 1989 and is a privately held corporation based in Meridian, ID. PKG, Inc. specializes in contract design, development, and manufacturing of system-level devices with expertise in human-machine interfaces. With experience in medical, aerospace, government, and industrial products, PKG helps raise your company to the next level by leveraging our engineering and technology integration skills across your product lines. With a complete in-house vertical integration of expertise, services, manufacturing processes, and technologies, PKG provides our customers with all of their product development and manufacturing needs. Besides our expertise in system-level devices and human-machine interfaces, PKG also offers incubation and acceleration services for startup businesses and entrepreneurs.

Last Month CBBT announced PKG, Inc. is to become the key manufacturer for ClearMask, LLC and Xometry. See the person, not the mask. The first fully transparent, FDA-cleared mask produced in the United States is made possible through a manufacturing partnership between ClearMask LLC, Xometry, and PKG Inc. ClearMask™ is the world’s first FDA-cleared, fully transparent surgical mask suitable for hospitals, clinics, schools, retail, hospitality, and other settings. The mask is optimized for maximum clarity and comfort and meets applicable ASTM Level 3 requirements for fluid resistance and flammability, which offers a high level of protection for medical use in environments such as operating rooms. To meet the rigorous controls necessary for FDA-cleared products, ClearMask LLC and Xometry, the largest marketplace for On-Demand manufacturing, partnered with PKG Inc., an ISO 13485-certified facility, to manufacture the FDA-cleared version of the ClearMask™. PKG will provide valuable experience in building FDA-approved products, enabling mass production while achieving rigorous oversight and high quality.

This November, PKG Inc. officially kick-started a new production floor designed to meet the mass production of the FDA-cleared ClearMask™, which has been in high demand. Over the next few weeks, PKG Inc. intends to fully transition company ownership to Cerebain Biotech Corporation in an acquisition that began in the middle of this year. Upon completion, under the Cerebain Biotech umbrella, PKG Inc. will continue its support in mass-producing large volumes of the FDA-cleared ClearMask™. Almir Garibovic stated “We are proud to help ClearMask fight against the pandemic with a smile on our face that everyone can see. All of us are looking forward to successfully providing innovative accessibility and protection to a diverse population.”

“In this disheartening time as the world fights against the COVID-19 pandemic, the ClearMask™ helps protect while bringing much-needed relief through a reassuring smile and familiar face among fear and confusion and suffering. In addition to blocking particles or droplets with its fully transparent, anti-fog plastic barrier, the ClearMask™ helps improve visual communication, which may help avoid costly errors and adverse outcomes. Transparent communication during the customer experience can be critical in establishing rapport and earning trust while assuring safety as a priority,” announced ClearMask in its press release.

For More on PKG Subscribe Right Now

CBBT is making a spectacular run up the charts in recent months as the company completes the acquisition of PKG, Inc., a developer, and manufacturing company for system-level devices that has worked with numerous Fortune 500 companies over the years. Last Month PKG reported it is set to become the key manufacturer for ClearMask; the first fully transparent, FDA-cleared mask produced in the United States. To meet the rigorous controls necessary for FDA-cleared products, ClearMask LLC and Xometry, the largest marketplace for On-Demand manufacturing, partnered with PKG Inc., an ISO 13485-certified facility, to manufacture the FDA-cleared version of the ClearMask™.  The mask is optimized for maximum clarity and comfort and meets applicable ASTM Level 3 requirements for fluid resistance and flammability, which offers a high level of protection for medical use in environments such as operating rooms. For the past 30 years PKG has been a major contributor in designing and manufacturing numerous and diverse devices for Fortune 500 companies, mid-size organizations, and start-up businesses. With complete in-house vertical integration, PKG provides its customers with all of their product development needs from R&D, design & development, verification & validation, final product manufacturing, product testing, service and warranty and end of life product support and transitioning. CBBT has just 643 Million shares outstanding with OS topped at 1.25 million. According to communications received from Eric Clemons, the Company is finazling its acquisition of PKG Inc. by the end of the year with the Company’s legal department in charge. There is still a significant amount of documentation that needs to be addressed before the acquisition can be completed. Microcapdaily first reported on CBBT when the stock was $0.002. We will be updating on CBBT when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CBBT.

Disclosure: we hold no position in CBBT either long or short and we have not been compensated for this article.

Ali Raza
A journalist, with experience in web journalism and marketing. Ali holds a master degree in finance and enjoys writing about cryptocurrencies and fintech. Ali’s work has been published on a number of cryptocurrency publications.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.